ixazomib and pharmaceutically acceptable salts and esters thereof, such as ixazomib citrate

摘要

The present invention provides novel compounds useful as proteasome inhibitors. The invention also provides pharmaceutical compositions comprising the compounds of the invention and methods of using the compositions in the treatment of various diseases.